First Horizon Corporation’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.25M Buy
342,754
+13,476
+4% +$353K 0.32% 88
2026
Q1
$9.25M Buy
329,278
+122,904
+60% +$3.27M 0.39% 85
2025
Q4
$5.14M Sell
206,374
-51,915
-20% -$1.31M 0.23% 109
2025
Q3
$6.58M Buy
+258,289
New +$6.38M 0.31% 98
2021
Q2
$3.8M Buy
96,993
+19
+0% +$739 0.34% 88
2021
Q1
$3.51M Buy
96,974
+3,448
+4% +$122K 0.33% 91
2020
Q4
$3.44M Sell
93,526
-4,969
-5% -$182K 0.34% 86
2020
Q3
$3.43M Buy
+98,495
New +$3.45M 0.37% 85
2013
Q2
$2.97M Buy
+111,611
New +$3.08M 0.81% 26

Other funds holding PFE

First Horizon Corporation's PFE Position: Q2 2026 in Review

First Horizon Corporation increased its Pfizer (PFE) stake by 4.1% in Q2 2026, buying an estimated $353K and bringing the position to 342,754 shares worth $8.25M. The position accounts for 0.32% of the portfolio, ranked #88.

First Horizon Corporation first reported a position in PFE in Q2 2013 and has held it in 9 quarters since. The position peaked at $9.25M in Q1 2026. 1,496 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • First Horizon Corporation held 342,754 shares of Pfizer worth $8.25M as of Q2 2026.
  • First Horizon Corporation bought 13,476 Pfizer shares in Q2 2026, an estimated $353K.
  • Pfizer made up 0.32% of First Horizon Corporation's portfolio in Q2 2026, its #88 holding.
  • First Horizon Corporation first reported a position in Pfizer in Q2 2013 and has held it in 9 quarters since.
  • First Horizon Corporation's Pfizer position peaked at $9.25M in Q1 2026.
  • 1,496 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.